From: Cost comparison between uterine-sparing fibroid treatments one year following treatment
MRgFUS patients (N = 48) | N | % |
---|---|---|
Age of patient | ||
25-34 | 2 | 4.2% |
35-44 | 20 | 41.7% |
45-54 | 25 | 52.1% |
55-64 | 1 | 2.1% |
Plan type | ||
Fee for service | 2 | 4.2% |
Preferred Provider Organization (PPO) | 27 | 56.3% |
Point of Service (POS) | 4 | 8.3% |
Health Maintance Organizations (HMO) | 9 | 18.8% |
Capitated POS | 1 | 2.1% |
Consumer Driven Health Plan (CDHP) | 4 | 8.3% |
Unknown | 1 | 2.1% |
Sociodemographics of ZIP Code of residence | ||
Median household income | ||
Quintile 1 ($0,$28,280) | 2 | 4.2% |
Quintile 2 ($28,281, $33,680) | 1 | 2.1% |
Quintile 3 ($33,681, $39,204) | 6 | 12.5% |
Quintile 4 ($39,205, $48,749) | 14 | 29.2% |
Quintile 5 (≥$48,750) | 25 | 52.1% |
% over 25 with college degree | ||
Quintile 1 (0-7%) | 1 | 2.1% |
Quintile 2 (8-11%) | 0 | 0.0% |
Quintile 3 (12-15%) | 10 | 20.8% |
Quintile 4 (16-24%) | 11 | 22.9% |
Quintile 5 (≥25%) | 26 | 54.2% |
% Black | ||
Quintile 1 (0%) | 0 | 0.0% |
Quintile 2 (0.1-0.3%) | 2 | 4.2% |
Quintile 3 (0.4-1.3%) | 6 | 12.5% |
Quintile 4 (1.4-8.5%) | 27 | 56.3% |
Quintile 5 (≥8.6%) | 13 | 27.1% |
Employment details | ||
Employee (not spouse or dependent) | 35 | 72.9% |
Active fulltime | 24 | 50.0% |
Salaried | 13 | 27.1% |
MRgFUS procedures (N = 54) | ||
Cost of first procedure (N = 48) | $ | |
Employer | $6,425 | |
Out-of-pocket | $902 | |
Mean | $7,327 | |
Std. Dev. | $6,521 | |
Year of procedure | ||
2004 | 0 | 0.0% |
2005 | 3 | 5.6% |
2006 | 7 | 13.0% |
2007 | 11 | 20.4% |
2008 | 13 | 24.1% |
2009 | 12 | 22.2% |
2010 | 8 | 14.8% |
Surgical setting | N | % |
Inpatient | 1 | 1.9% |
Outpatient | 53 | 98.1% |
Inclusion or exclusion in study sample | N | % |
Met study inclusion criteria | 14 | 25.9% |
Excluded from study sample | ||
Had other surgeries coded at index (multiple procedures) | 3 | 5.6% |
Incomplete baseline and/or follow-up | 31 | 57.4% |
Not the index procedure (Patient had a prior surgical treatment for UF) | 6 | 11.1% |